A radiometric assay for aspartoacylase activity in human fibroblasts: application for the diagnosis of Canavan's disease

Varda Barash*, Daphna Flhor, Bilha Morag, Avihu Boneh, Orly N. Elpeleg, Chaim Gilon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

A new sensitive method for measuring aspartoacylase activity in human skin fibroblasts using [3H]N-acetyl-L-aspartic acid (NAA) is described. Optimal assay conditions and kinetic parameters for enzyme activity were determined. The enzyme was found to have maximal activity at pH 8.5, and the Michaelis constant for the substrate N-acetylaspartate was 1.8-2.0 mmol/l. Aspartoacylase activity in control cultured human fibroblasts was 9.2 ± 1.8 nmol/h per mg protein, compared with 1.1 ± 0.2 in seven Canavan patients and 3.5 ± 0.9 in four patients' parents. This method for determining aspartoacylase activity is advantageous to the previously described spectrophotometric method since it is rapid, more sensitive and has less nonspecific interference. It is possible that application of this technique to cultured ammniotic and chorionic villi cells may be used for prenatal diagnosis of Canavan's disease.

Original languageEnglish
Pages (from-to)175-181
Number of pages7
JournalClinica Chimica Acta
Volume201
Issue number3
DOIs
StatePublished - 30 Sep 1991

Keywords

  • Aspartoacylase
  • Canavan's disease
  • Leukodystrophy
  • Spongy degeneration of brain

Fingerprint

Dive into the research topics of 'A radiometric assay for aspartoacylase activity in human fibroblasts: application for the diagnosis of Canavan's disease'. Together they form a unique fingerprint.

Cite this